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Abstract
Objective: The aim of this study was to determine the biological effects of natural dietary intake of vitamin K
as phylloquinone (K1) and menaquinone-4 (MK-4) and a control diet also containing menadione (K3)o n
levels of K1 and total MK-4 (menaquinone-4) and menaquinone-4-2,3-epoxide (MK-4O) in liver and
pancreas, and on femur bending resistance in a fast-growing animal model.
Design: Chickens were fed four wheat-based diets from day 11 to day 22 after hatching. The diets contained
different combinations of fat sources: rapeseed oil, animal rendered fat, soybean oil and hydrogenated
soybean oil. Concentration of K1 in the three experimental diets was 120 ng/g whereas MK-4 levels were 23,
52 and 63 ng/g respectively. The control diet contained 157 ng K1/g, 75 ng MK-4/g and 2.250 ng K3/g.
Results: Growth rates and femur strength confirmed adequate supply of nutrients and vitamin K in the test
groups. There were no significant differences in femur bending resistance among the test groups, but these
were higher than the control. K1, MK-4 and MK-4O were found in liver. In pancreas, mainly MK-4O was
found with small amounts of MK-4, but none had content of K1. In the test groups the hepatic levels of
MK-4 and MK-4O reflected the dietary intake of MK-4.
Conclusion: The chickens were in good health with good bone resistance without supplements of K3 in
the feed, but at least a natural content of 23 ng MK-4/g feed. Liver and pancreas appears to use MK-4
in different ways.
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I
t has been shown experimentally that oral absorption
of phylloquinone (vitamin K1;K 1) is higher
when it is taken as a pharmaceutical preparation than
when it is taken as part of a meal in which the vitamin
is naturally present (1). Dietary K1 as well as the closely
related menaquinone-4 (MK-4) are transported with diff-
erent lipoproteins in the blood (2). Different tissues
have different mechanisms of uptake of vitamin-carrying
plasma proteins, resulting in differences in the equili-
brium concentrations of K1 and MK-4 (3, 4). There is
also evidence that MK-4 can be synthesized in tissues
from menadione (vitamin K3;K 3), either as such (5),
derived from K1 (69), or by direct substitution (10).
In many of these studies the experimental animals
were deprived of vitamin K or given overly high doses
of K1.
Chickens have been bred for high utilization of feed
and high rates of growth. During the first 3 weeks of
life a typical chicken will increase its body mass by a
factor of 20. Chickens cannot perform de novo synthesis
of vitamin K; hence the tissue levels of vitamin K
measured after the feeding period would in some way
have to be related to the dietary intake. Any vitamin K
present at the start of experimental feeding would provide
only a limited fraction of the total amount present. Liver
is the main site of synthesis for vitamin K-dependent
coagulation factors and has been shown to possess
the apparatus necessary to synthesize MK-4 (5, 7, 9).
Pancreas has been reported to have higher values of
MK-4 than most other tissues, possibly owing to K1-
to-MK-4 conversion (11, 12) and possibly related to the
secretion of MK-4 in pancreatic juice (13). In chickens,
the activity of epoxide reductase per gram tissue has
been found to be 10% of the activity in rats (6),
explaining why a high proportion of the vitamin K
material of chickens is present as the 2,3-epoxide.
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ordinary dietary doses of vitamin K would influence
tissue accumulation of K1 and MK-4. Care was taken
to vary only the dietary concentration of MK-4 together
with an adequate and stable concentration of K1, and
in an identical feed matrix so as to limit any feed-
induced variations in bioavailability. For comparison
regarding the adequacy of the feeds a control group
receiving the standard chicken feed containing additional
K3 was included.
Vitamin Kdependent carboxylation of bone matrix
proteins is regarded as important for bone matrix calci-
fication (14). Bone strength was measured to investigate
whether our modest variations in vitamin K content
could be detected in this system.
Methods
Chickens
Fifty-seven newly hatched male chickens (Samvirke
kylling Norway, Ross 308) from the same hatching
farm were used in this experiment conducted at The
Norwegian University of Life Sciences. Animal treatment
and animal facilities all complied with the Guide for the
Care and Use of Laboratory Animals (15). The experi-
mental animal research followed internationally recog-
nized guidelines. All animals were cared for according
to Norwegian laws and regulations for experiments with
live animals (The Animal Protection Act of December
20th, 1974, and the Animal Protection Ordinance Con-
cerning Experimentswith Animals of January 15th, 1996).
Experimental design
The chickens were randomly assigned into one of four
dietary 22 day treatments. During the first 10 days each
group of 14 to 15 animals were kept in deep littered
pens; 75 cm150 cm. At day 10 they were weighed
and individually placed in wire-floored metabolism
cages up until day 22. The chickens were raised in an
environmentally controlled room. The room temperature
was maintained at 328Cf r o md a y s0 3, then gradually
reduced by 0.58C per day until day 22. They were
exposed to 23 h light and 1 h dark photoperiod days
07, the next 2 weeks they were exposed to 24 h dark;
the dark periods were between 1721 h and 0004 h.
The chickens had free access to feed and water. Water
troughs and wire-floors were cleaned daily, with small
possibility of coprophagy. Feed intake and body weight
were registered day 11 to day 22. None of the birds were
sick or died during the feeding period.
Sampling
At day 22 the chickens were weighed, killed by carbon
dioxide narcosis and dissected immediately after death.
Organs and limbs were packed in aluminum foil, frozen
in liquid nitrogen and stored at 208C before being
analyzed.
Vitamin K in diets
Rapeseed oil was purchased from AFB, Askim, Norway
and contained 60% oleic acid, 20% linoleic acid and
10% alpha linolenic acid. Rendered animal fat (RAF)
was obtained locally and contained fat from ruminants
(about 70%) and pigs (about 30%). The composition of
RAF was (by weight): 26% palmitic acid, 18% stearic
acid, 36% oleic acid and 8% linoleic acid. Fully hydro-
genated soybean oil (HSO), refined to remove K1
and ineffective dihydrophylloquinone together with
trans-fatty acids, were purchased from AAK (Aarhus-
Karlshamn) Sweden AB. The level of K1 in HSO was less
than 10% of the original amount in untreated soybean oil.
Dihydrophylloquinone was not detected in the oils.
All four feeds were wheat based and composed accord-
ing to guidelines adjusted to the requirements of chickens
(Table 1). The feeds were manufactured at ForTek, Aas,
Norway, with a matrix type 2.5 mm46 mm at a rate
of 600 kg/h. They had the same basic composition with
regard to protein, carbohydrates, minerals and vitamins
except vitamin K. All diets contained lipid in the form
of oils and solid fats. The control (CTR) feed group
contained vitamin K1 from rapeseed oil and soy bean
oil; MK-4 from RAF and added K3. The experimental
feeds contained natural levels of K1 and MK-4 from
Table 1. Composition of the experimental feeds including levels of
vitamin K
Ingredients CTR MIX RAF HSO
Wheat (%) 60 60 60 60
Soybean meal (%) 20 20 20 20
Fish meal (%) 3 3 3 3
Rapeseed oil (%) 5 0 0 0
Animal Rendered fat (%) 5 4 8 0
Soybean oil (%) 0 2 2 2
Hydrogenated soybean oil (%) 0 4 0 8
Mineral mixture
a (%) 0.15 0.15 0.15 0.15
Vitamin mixture
a (%) 0.08 0.08 0.08 0.08
MK-4 (ng/g feed) 75.3 62.5 51.6 22.6
K1 (ng/g feed) 157.2 120.4 119.8 119.1
K3 ( ng/g feed) 2,250 
Notes: All feeds contained Monocalcium phosphate 2%; Ground
limestone 1.85%; NaCl 0.25%; DL-Methionine 0.4%, L-lysine 0.3%;
L-Threonine 0.1%; Choline chloride 0.13% and MgO 6.5710
3%.
aVitamin and mineral mixture provided the following per kg feed: retinyl
acetate, 2.7 mg; cholecalsiferol, 0.07 mg; DL-alpha tocopheryl acetate,
38 mg; pyridoxine, 3.4 mg; riboflavin, 9 mg; Ca-pantothenate, 12.5 mg;
biotin, 0.19 mg; thiamine, 1.9 mg; niacin, 37.5 mg; cobalamine, 0.02 mg;
folic acid, 1.5 mg; choline chloride, 500 mg; manganese, 75 mg; zinc,
75 mg; iron, 95 mg; cupper, 10 mg; iodine, 0.6 mg; selenium, 0.43 mg.
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and fully HSO (MIX). The experimental diets contained
2% natural soybean oil to provide a small supplement
of K1 (Table 1). K1 content of the control diet was
32% higher than the experimental feeds. The experi-
mental feeds had MK-4 levels from 20 to 50% of the
K1 level.
Vitamin K analysis
Vitamin K in liver, pancreas and feeds were analyzed
by HPLC using a C-18 reversed phase column and
fluorometric detection after postcolumn electrochemical
reduction according to Thijssen et al. (16).
Testing of bone strength
The right femur was thawed gently and dissected free
of muscle. Bending resistance was tested in a TA-XT2
texture analyzer from Stable Micro Systems, Godal-
ming, Surrey, UK (www.stablemicrosystems.com). Probe
velocity was at 0.1 mm/s, and the distance between
the supports was 32.5 mm. Load-versus-time curves
were generated and analyzed by means of Texture
Expert Exceed v2.64 software. Bending resistance was
calculated from the initial linear segment of the graphs
and expressed as N/mm.
Statistical analyses
Statistical calculations (linear regression) on the effect of
the four dietary treatments were performed by SPSS 15.0
IBM SPSS, Statistical Analyses Software (http://
www.spss.com/), using comparative means by one-way
ANOVA and Bonferroni test for assumption of equal
variances.
Results
Chicken growth
Weight at day 11 and 22 showed that the chickens in
the experimental groups ate slightly more and the RAF
and HSO group grew significantly faster than the MIX
and CTR groups indicating a satisfactory nutritional
status (Table 2).
Total amount of MK-4 eaten by the chicken was
significantly different, being highest in the CTR group
and lowest in the HSO group, while for K1 no diffe-
rence between experimental group but significantly
higher in the control group (Table 2).
Vitamin K in liver and pancreas
Pancreas had higher vitamin K concentration than
liver (Table 3). In liver, MK-4 was the most abundant
vitamer, while in pancreas MK-4O was the main vitamer.
K1 was not detected in pancreas (Table 3). The associa-
tion between the amounts of MK-4 consumed and MK-4
in liver was statistically significant.
The concentration of total MK-4 and MK-4O in
pancreas as well as in liver is associated with MK-4
consumed.
Bone strength
The bending resistance of the femur was slightly higher
in the experimental groups than in the control group,
with no difference between the experimental groups
(Table 3).
Table 2. Information on feed and weight of the chicken from day 11
to day 22
CTR MIX RAF HSO
nnumber of
chickens
15 14 14 14
Chicken weight
day 11 (g)
268 (18)
a,c,d 243 (13)
b,d 274 (16)
a,c 256 (13)
a,b,d
Chicken weight
day 22 (g)
800 (84)
a 827 (48)
a 939 (68)
b 936 (63)
b
Liver weight (g) 28 (3)
a,b 27 (3)
a 30 (3)
b 30 (5)
b
Feed intake (g) 680 (72)
a 701 (41)
a,b 746 (51)
b 766 (64)
b
K1 intake (mg) 107 (11)
a 84 (5)
b 90 (6)
b 92 (8)
b
MK-4-intake
(mg)
51 (5)
a 44 (3)
b 38 (3)
c 17 (1)
d
K1 intake (mg) 1,530
Notes: Values are means and SD.
adMeans with different letters within the same row are significantly
different at the 5% level.
Table 3. Levels of vitamin K in liver and pancreas and femur
bending resistance
CTR MIX RAF HSO
Liver
K1 (ng/g) 47 (11)
a 28 (11)
b 35 (16)
a 26 (12)
b
MK-4 (ng/g) 425 (66)
a 238 (56)
b 105 (22)
c 59 (14)
d
MK-4O (ng/g) 104 (29)
a 80 (25)
b 38 (16)
c 23 (16)
d
MK-4/(MK-4MK-4O)% 75 (9) 66 (11) 64 (14) 63 (20)
Pancreas
MK-4O (ng/g) 1,158 (617)
a 522 (351)
b316 (186)
c118 (61)
d
MK-4 (ng/g) 59 (86) 32 (49) 7 (9) 11 (9)
MK-4/(MK-4MK-4O)% 5 (13) 6 (13) 2 (4) 9 (9)
Femur
Bending resistance
(N/mm)
85 (10)
a 96 (13)
b 98 (11)
b 102 (12)
b
Notes: Values are means and SD.
adMeans with different letters within the same row are significantly
different at the 5% level.
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It has long been known that MK-4 is being synthesized
in tissues of animals. Our experimental model seems to
suggest that conversion of K1 to MK-4 did not take
place in the presence of adequate levels of MK-4 in the
feed, not even in the feed group with the lowest level
of MK-4 (HSO). In the test groups the hepatic levels of
MK-4 and MK-4O reflected the dietary intake of MK-4.
Recently, a specific enzyme that converts K1 to MK-4
has been discovered and described (10). The production
capacity of this enzyme has not been compared with or
distinguished from the menadione prenylation system (5),
so published evidence is as yet insufficient for a full
quantitative picture of the various sources and pathways
of synthesis in normally fed animals. MK-4O was in a
different way dependent on the vitamin in the feed. The
control group had the highest MK-4O levels in pancreas.
This could be related to the supplementary K3 given to
that group only. Liver and pancreas appears to use
MK-4 in different ways; in liver 1/3 of MK-4 is converted
to MK-4O while in pancreas almost all is as MK-4O.
The content of K1 in liver was higher in the control
group. The feed for this group contained more K1 and K3
was added.
Conclusion
The chickens were in good health with good bone
resistance without supplements of K3 in the feed but
at least a natural content of 23 ng MK-4/g feed. Liver
and pancreas appears to use MK-4 in different ways.
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